Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

MARCIUS

Financiado

Cerrado

MARie Curie Intelligent UltraSound

Cardiovascular diseases (CVD) are the number one cause of death in EU. Echocardiography is the most important imaging tool to assess cardiac function, since it is real time, cost effective and can be performed without discomfort a... ver más

30/09/2023

UNIVERSITY OF SOUT...

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

UNIVERSITETET I SOROST-NORGE No se ha especificado una descripción o un objeto social para esta compañía.

Fecha límite participación Sin fecha límite de participación.

Ver 9 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2023-09-30

MSCA-ITN-2019: Innovative Training Networks

I+D

Cerrada hace 6 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

9 Participantes

UNIVERSITY OF SOUTH-EASTERN...

584.68K€ | Lider

FRUTAS EL DULZE

INGENIA TECNOLOGIA

RIEGOS DE LEVANTE MURCIA

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

AI-driven cardiac ultrasound analysis AI-driven cardiac ultrasound analysis 4M€ Cerrado

AI4CMR AI-based clinical software for fully automated Cardiac Magne... 3M€ Cerrado

RYC-2011-08174 Advanced Image Processing and Machine Learning for the Analy... 184K€ Cerrado

WILLEM: AI to Reduce Cardiovascular Diseases WILLEM: AI to Reduce Cardiovascular Diseases 4M€ Cerrado

TED2021-129774B-C21 NUEVAS HERRAMIENTAS Y MODELOS PARA PREDECIR LA PROGRESION DE... 300K€ Cerrado

SCAUT DECISIO Preventive and Personalised Remote Care for Heart Patients 3M€ Cerrado

Duración del proyecto: 51 meses Fecha Inicio: 2019-06-24
Fecha Fin: 2023-09-30

Líder del proyecto

UNIVERSITETET I SOROST-NORGE No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 2M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Cardiovascular diseases (CVD) are the number one cause of death in EU. Echocardiography is the most important imaging tool to assess cardiac function, since it is real time, cost effective and can be performed without discomfort and harmful radiation. A typical cardiac ultrasound examination takes 30-40 min, with image analysis and reporting doubling this time. Thus, cardiologists are now calling for a step change in diagnostic speed and accuracy to allow significant improvements for the care of CVD patients. We propose to develop intelligent algorithms to provide diagnostic support by automatic interpretation of regional cardiac contraction patterns and myocardial image texture. MARCIUS will leverage recent progress in machine learning to train a neural network to recognize unique disease states using a large database of patient data with known pathophysiology and outcome augmented with virtual patient data obtained using a well-validated mathematical model of the heart and circulatory system in combination with a beyond the state-of-the-art ultrasound simulation tool. The resulting diagnostic algorithm will be validated clinically. MARCIUS will take on research activities with high added value, both clinically for patients suffering from cardiac diseases, commercially for the industrial beneficiary and societally with reducing healthcare costs. The long-term and high-risk aspect of these activities makes them unsuited for execution within a normal product development context. Through training and knowledge development in a focused research project built on a unique combination of state-of-the-art technologies, MARCIUS will provide Europe with researchers trained with the cross-disciplinary understanding and skills necessary to develop enabling technologies in an industrial and clinical setting. The longer-term outcome of the project is new products, which will benefit patients across Europe directly by advancing the state of care within cardiology.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores